Search research articles
Contact Us
Filters
Showing results (31-40 of 965) with videos related to
Page
of 97
Sort By:
Cancer Research Communications
|
May 5, 2025
APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer
Nina Marie G Garcia, Jessica N Becerra, Sharan Srinivasan, et al.
Cancer Research Communications
|
May 5, 2025
Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection
Eric A Klein, Timothy R Church, Christina A Clarke, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
Cancer Research Communications
|
October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
Cancer Research Communications
|
August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cancer Research Communications
|
August 18, 2025
Impact of Staging, Histologic Grading, and Racial Background on Lip Cancer Survival in the United States: Insights from the SEER Database (2010-2020)
Muhammad Taqi, Syed Jaffar Abbas Zaidi
Cancer Research Communications
|
September 8, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Michelle Choe, Danielle Kirkey, Isabel Lira, et al.
Cancer Research Communications
|
September 18, 2025
A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors
Christopher H Lieu, Heinz-Josef Lenz, Al B Benson, et al.
Cancer Research Communications
|
September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown Significance
Soohwan Park, Masachika Ikegami, Rina Kitada, et al.
Cancer Research Communications
|
September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Page
of 97
Search research articles
Search
Showing results (31-40 of 965) with videos related to
Sort By:
Page
of 97
Cancer Research Communications
|
May 5, 2025
APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer
Nina Marie G Garcia, Jessica N Becerra, Sharan Srinivasan, et al.
Cancer Research Communications
|
May 5, 2025
Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection
Eric A Klein, Timothy R Church, Christina A Clarke, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
Cancer Research Communications
|
October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
Cancer Research Communications
|
August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cancer Research Communications
|
August 18, 2025
Impact of Staging, Histologic Grading, and Racial Background on Lip Cancer Survival in the United States: Insights from the SEER Database (2010-2020)
Muhammad Taqi, Syed Jaffar Abbas Zaidi
Cancer Research Communications
|
September 8, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Michelle Choe, Danielle Kirkey, Isabel Lira, et al.
Cancer Research Communications
|
September 18, 2025
A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors
Christopher H Lieu, Heinz-Josef Lenz, Al B Benson, et al.
Cancer Research Communications
|
September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown Significance
Soohwan Park, Masachika Ikegami, Rina Kitada, et al.
Cancer Research Communications
|
September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
Emily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Page
of 97